New Jersey § 24:6j-5

§ 24:6j-5.

a. If an opioid antidote is administered by a health care practitioner or a first responder to a person believed to be experiencing a drug overdose, an opioid antidote and information concerning substance use disorder treatment programs and resources and sterile syringe access programs and resources, including information on the availability of opioid antidotes , shall be provided to the person as follows: (1) If the person is admitted to a health care facility or receives treatment in the

emergency department of a health care facility, a staff member designated by the health

care facility, who may be a social worker, professional counselor, licensed or certified alcohol or drug counselor, or other appropriate professional, shall offer to furnish the person, or a family member or friend of the person in attendance

during the patient's admission or emergency department visit, with an opioid antidote

upon discharge, along with information regarding the cost of the opioid antidote,

and shall provide the information concerning substance use disorder treatment programs and resources and sterile syringe

access programs and resources to the person at any time after treatment for the drug overdose is complete, but

prior to the person's discharge from the facility. The designated staff member shall document the provision of the information and the dispensing of an opioid antidote to the person or to a family member or friend

of the person, if an opioid antidote is dispensed, in the person's medical record, and may, in collaboration with an appropriate health

care practitioner , additionally develop an individualized substance use disorder treatment plan for the person. (2) If the opioid antidote is administered by a first responder and the person believed to be experiencing an overdose is not subsequently transported to a health care facility, the first responder shall offer to furnish the person with an opioid antidote and shall provide the information concerning substance use disorder treatment programs and resources and sterile syringe

access programs and resources to the person at the time treatment for the drug overdose is complete. First responders shall maintain an adequate supply of opioid antidotes, in excess

of the supply needed to meet the anticipated demand for opioid antidotes to treat

individuals believed to be experiencing an opioid overdose, as is necessary to ensure

people treated for a suspected opioid overdose can be furnished with an opioid antidote

at the time treatment for the overdose is complete. b. As used in this section: “ First responder ” means a law enforcement officer, paid or volunteer firefighter, paid or volunteer

member of a duly incorporated first aid, emergency, ambulance, or rescue squad association,

or any other individual who, in the course of that individual's employment, is dispatched

to the scene of an emergency situation for the purpose of providing medical care or

other assistance. “ Health care facility ” means a health care facility licensed pursuant to P.L.1971, c. 136 ( C.26:2H-1 et seq. ). “ Opioid antidote ” means any drug, regardless of dosage amount or method of administration, which has

been approved by the United States Food and Drug Administration (FDA) for the treatment

of an opioid overdose. “Opioid antidote includes, but is not limited to, naloxone hydrochloride, in any

dosage amount, which is administered through nasal spray or any other FDA-approved

means or methods. c. The Commissioner of Human Services shall develop informational materials concerning

substance use disorder treatment programs and resources and sterile syringe access programs and resources, and information on the availability of opioid antidotes , for dissemination to health care practitioners and first responders to facilitate the provision of information to persons who are treated for a suspected overdose as provided in this section.